381 related articles for article (PubMed ID: 33738696)
1. Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA.
Patelli G; Vaghi C; Tosi F; Mauri G; Amatu A; Massihnia D; Ghezzi S; Bonazzina E; Bencardino K; Cerea G; Siena S; Sartore-Bianchi A
Target Oncol; 2021 May; 16(3):309-324. PubMed ID: 33738696
[TBL] [Abstract][Full Text] [Related]
2. Clinical Utility of Analyzing Circulating Tumor DNA in Patients with Metastatic Colorectal Cancer.
Nakamura Y; Yoshino T
Oncologist; 2018 Nov; 23(11):1310-1318. PubMed ID: 29700206
[TBL] [Abstract][Full Text] [Related]
3. Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer.
Zhou H; Zhu L; Song J; Wang G; Li P; Li W; Luo P; Sun X; Wu J; Liu Y; Zhu S; Zhang Y
Mol Cancer; 2022 Mar; 21(1):86. PubMed ID: 35337361
[TBL] [Abstract][Full Text] [Related]
4. Liquid biopsy in ovarian cancer: recent advances on circulating tumor cells and circulating tumor DNA.
Giannopoulou L; Kasimir-Bauer S; Lianidou ES
Clin Chem Lab Med; 2018 Jan; 56(2):186-197. PubMed ID: 28753534
[TBL] [Abstract][Full Text] [Related]
5. The Application of Circulating Tumor DNA in the Screening, Surveillance, and Treatment Monitoring of Colorectal Cancer.
Xie H; Kim RD
Ann Surg Oncol; 2021 Mar; 28(3):1845-1858. PubMed ID: 32776184
[TBL] [Abstract][Full Text] [Related]
6. Dynamic liquid biopsy components as predictive and prognostic biomarkers in colorectal cancer.
Raza A; Khan AQ; Inchakalody VP; Mestiri S; Yoosuf ZSKM; Bedhiafi T; El-Ella DMA; Taib N; Hydrose S; Akbar S; Fernandes Q; Al-Zaidan L; Krishnankutty R; Merhi M; Uddin S; Dermime S
J Exp Clin Cancer Res; 2022 Mar; 41(1):99. PubMed ID: 35292091
[TBL] [Abstract][Full Text] [Related]
7. Circulating Tumour Cells, Circulating Tumour DNA and Circulating Tumour miRNA in Blood Assays in the Different Steps of Colorectal Cancer Management, a Review of the Evidence in 2019.
Christou N; Meyer J; Popeskou S; David V; Toso C; Buchs N; Liot E; Robert J; Ris F; Mathonnet M
Biomed Res Int; 2019; 2019():5953036. PubMed ID: 31930130
[TBL] [Abstract][Full Text] [Related]
8. Cell-Free DNA in the Management of Colorectal Cancer.
Harlé A
Recent Results Cancer Res; 2020; 215():253-261. PubMed ID: 31605233
[TBL] [Abstract][Full Text] [Related]
9. Liquid biopsy in gastric cancer: predictive and prognostic biomarkers.
Zhang Z; Wu H; Chong W; Shang L; Jing C; Li L
Cell Death Dis; 2022 Oct; 13(10):903. PubMed ID: 36302755
[TBL] [Abstract][Full Text] [Related]
10. Role of circulating tumor DNA in the management of patients with colorectal cancer.
Moati E; Taly V; Didelot A; Perkins G; Blons H; Taieb J; Laurent-Puig P; Zaanan A
Clin Res Hepatol Gastroenterol; 2018 Oct; 42(5):396-402. PubMed ID: 29627453
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of circulating tumor DNA for colorectal cancer.
Osumi H; Shinozaki E; Yamaguchi K; Zembutsu H
Cancer Sci; 2019 Apr; 110(4):1148-1155. PubMed ID: 30742729
[TBL] [Abstract][Full Text] [Related]
12. The potential of liquid biopsy in the management of cancer patients.
Markou A; Tzanikou E; Lianidou E
Semin Cancer Biol; 2022 Sep; 84():69-79. PubMed ID: 35331850
[TBL] [Abstract][Full Text] [Related]
13. Circulating Cell-Free DNA and Colorectal Cancer: A Systematic Review.
Vymetalkova V; Cervena K; Bartu L; Vodicka P
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30373199
[TBL] [Abstract][Full Text] [Related]
14. Role of liquid biopsies in colorectal cancer.
Wills B; Gorse E; Lee V
Curr Probl Cancer; 2018 Nov; 42(6):593-600. PubMed ID: 30268335
[TBL] [Abstract][Full Text] [Related]
15. Role of Circulating Tumor DNA in Colorectal Cancer.
Li H; Lu S; Zhou Z; Zhu X; Shao Y
Methods Mol Biol; 2023; 2695():227-236. PubMed ID: 37450122
[TBL] [Abstract][Full Text] [Related]
16. Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples.
Russano M; Napolitano A; Ribelli G; Iuliani M; Simonetti S; Citarella F; Pantano F; Dell'Aquila E; Anesi C; Silvestris N; Argentiero A; Solimando AG; Vincenzi B; Tonini G; Santini D
J Exp Clin Cancer Res; 2020 May; 39(1):95. PubMed ID: 32460897
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Strategies toward Clinical Implementation of Liquid Biopsy RAS/BRAF Circulating Tumor DNA Analyses in Patients with Metastatic Colorectal Cancer.
van 't Erve I; Greuter MJE; Bolhuis K; Vessies DCL; Leal A; Vink GR; van den Broek D; Velculescu VE; Punt CJA; Meijer GA; Coupé VMH; Fijneman RJA
J Mol Diagn; 2020 Dec; 22(12):1430-1437. PubMed ID: 32961317
[TBL] [Abstract][Full Text] [Related]
18. Liquid biopsy challenge and hope in colorectal cancer.
Burz C; Rosca A; Pop VV; Buiga R; Aldea C; Samasca G; Silaghi C; Sur D; Lupan I; Pricopie A
Expert Rev Mol Diagn; 2019 Apr; 19(4):341-348. PubMed ID: 30943811
[TBL] [Abstract][Full Text] [Related]
19. Incorporating BEAMing technology as a liquid biopsy into clinical practice for the management of colorectal cancer patients: an expert taskforce review.
García-Foncillas J; Alba E; Aranda E; Díaz-Rubio E; López-López R; Tabernero J; Vivancos A
Ann Oncol; 2017 Dec; 28(12):2943-2949. PubMed ID: 28945877
[TBL] [Abstract][Full Text] [Related]
20. Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review.
Petit J; Carroll G; Gould T; Pockney P; Dun M; Scott RJ
J Surg Res; 2019 Apr; 236():184-197. PubMed ID: 30694754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]